MIF has been reported to be overexpressed in multiple cancers, including gastric adenocarcinoma [16], head and neck squamous cell carcinoma [17], esophageal squamous cell carcinoma [18], colorectal [19], pancreatic [20], ovarian [21], and prostate [22] cancers. Here, MIF is linked to cancer.